University of North Carolina at Chapel Hill ( Site 0025) — Chapel Hill, North Carolina

University of North Carolina at Chapel Hill ( Site 0025) is a clinical research site located in Chapel Hill, North Carolina, United States 27514.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

University of North Carolina at Chapel Hill ( Site 0025) has participated in 1 clinical trials.

Therapeutic areas: Uterine Cervical Neoplasms.

Sponsors: Merck Sharp & Dohme LLC.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of North Carolina at Chapel Hill ( Site 0025)?

University of North Carolina at Chapel Hill ( Site 0025) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of North Carolina at Chapel Hill ( Site 0025) conducted?

University of North Carolina at Chapel Hill ( Site 0025) has 1 clinical trials on record. Their work covers Uterine Cervical Neoplasms.

Is University of North Carolina at Chapel Hill ( Site 0025) accredited by Crixeo Health?

University of North Carolina at Chapel Hill ( Site 0025) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of North Carolina at Chapel Hill ( Site 0025)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.